We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Got it.

Europe (UK): +44 1732 316319 | India: +91 20 71531039 | USA: +1 855 2596535

WEB DEMO
  • Home
  • About
    • Our Story
    • Why CRFweb?
    • Contact
      • Our locations
      • Europe – UK Office
      • India
    • Security and compliance
  • Solutions
    • The EDC process
    • eCRF
    • MedDRA
    • Randomization
    • ePRO
    • eDiary
    • Innovations Hub
  • Sectors
    • Medical Devices
    • Pharma-Biotech
    • CROs
    • Academia
    • Nutraceuticals
  • Resources
    • News
WEB DEMO
  • Home
  • About
    • Our Story
    • Why CRFweb?
    • Contact
      • Our locations
      • Europe – UK Office
      • India
    • Security and compliance
  • Solutions
    • The EDC process
    • eCRF
    • MedDRA
    • Randomization
    • ePRO
    • eDiary
    • Innovations Hub
  • Sectors
    • Medical Devices
    • Pharma-Biotech
    • CROs
    • Academia
    • Nutraceuticals
  • Resources
    • News

Articles

TO A BRIGHT NEW YEAR

January 4, 2021

2020 was a year many will want to forget. We aim to make 2021 a year to remember.


2020 was a challenging year for businesses across the world. Yet despite the challenges, Clindox experienced significant growth and recorded its most successful year to date. Here are just some of the highlights:

  • 20%  sales growth across key geographic markets of Europe, Israel and India.
  • 25% increase in active studies on the CRFWeb platform.
  • 30% growth in the Clindox team including new additions to the R&D, Customer Success and Finance teams.
  • Go-Live on one of the largest and most important studies for a department of the Indian government.
  • Contribution to the global fight against COVID19 in collaboration with an Indian HQ’d CRO.
  • Successful delivery of a 25-study program for a major medical device company.
  • Implementation of flexible working conditions to support business growth and achieve business continuity in the face of COVID19.
  • Major R&D efforts to innovate our CRFWeb platform. Look out for news coming soon on exciting and powerful new capabilities early in 2021.
  • Launch of the Clindox Innovation Hub to manage future product and service development and delivery!
  • Preparation of our Strategic Plan for the period 2021 to 2023 promising an exciting future for Clindox, the CRFWeb platform and our customers and partners!

All these activities help support our customers’ efforts to get medical devices and therapeutics to the patients that need them faster! We look forward to increasing our commitment in 2021 and beyond!

Wishing you all a bright and successful 2021!

Share Post
Paper trials V EDC – wha...

About author

About Author

mike oxlee

Other posts by mike oxlee

Related posts

Articles
Read more

Paper trials V EDC – what’s more cost-effective?

June 3, 2020
Continue reading
Articles
Read more

CRFWEB to the Rescue

May 1, 2020
Continue reading
ePRO
Articles
Read more

It’s been a productive year for the CRFweb team

December 18, 2019
Continue reading
Post-Approval-and-Post-Marketing-Research
Articles
Read more

Approaches for reducing clinical trial costs – why are we still using paper?

July 4, 2019
Continue reading
Beat the clock to medical device compliance
Articles
Read more

Beat the clock to medical device compliance

March 30, 2019
Continue reading

CRFWEB is a clinical trial software application by Clindox

Clindox-8-300x212

Policies

Privacy Policy
Security policy

UK

+44 1732 316319

India

+91 207 1531039

Social Links

Registered number: 526690 © Copyright CRFweb 2019

Web design Yorkshire by Feel Design